Home » Newsletters » BioWorld Science

BioWorld Science

March 20, 2012

View Archived Issues

Sangamo cell therapy increases CD4+ T-cell counts in patients with HIV

Novacta Biosystems develops novel candidate antibacterials

Phase I trial assesses interaction between diabetes therapies

Novel first-in-human data presented on Medimmune cancer immunotherapy

New data highlight role of lymphopoietin in chronic rhinosinusitis with nasal polyps

U.S. study links SNPs to complications after subarachnoid hemorrhage

Cartagenia enters partnership for rare epilepsy syndromes

Merck & Co. enters into collaboration to create new institute

Ampio provides update on Optina trial

Once-daily tramadol capsule launched in Canada for chronic pain

Alnylam launches phase I trial of transthyretin-mediated amyloidosis therapy

Provectus Pharmaceuticals reports topline phase II data on PH-10

QRxPharma and Actavis sign new licensing agreement

CUNY to validate diagnostic antibodies

Novel GPR124 receptor agonists designed in U.S.

New potential flu therapies presented

New nicotinic acetylcholine receptor ligands synthesized

Boehringer Ingelheim Pharma divulges new MPGES-1 inhibitors

Santhera reports novel mitochondrial function modulators

Avaxia receives second NIH grant for oral IBD immunotherapeutic

Merck & Co. to discontinue development of vernakalant formulation

AstraZeneca and Targacept give update on TC-5214 development

First once-daily 24-hour LABA for COPD maintenance launched in U.S.

Enrollment complete in phase III trials of allergy immunotherapy

Cellceutix enters collaboration agreement to support Kevetrin development

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...